Literature DB >> 3947172

Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state.

J K Kirklin, D E Chenoweth, D C Naftel, E H Blackstone, J W Kirklin, D D Bitran, J G Curd, J G Reves, P N Samuelson.   

Abstract

Nineteen patients were prospectively selected and studied before and after the administration of protamine sulfate following cardiopulmonary bypass (CPB). After protamine administration, C3a, C4a, and C4d were elevated; the peak levels of C3a and C4a were in samples taken 10 minutes after protamine administration while those of C4d were in those obtained at 5 hours. Only C3a was elevated after CPB and before protamine administration. In vitro, only the combination of protamine sulfate and heparin, and neither alone, resulted in increased C3a and C4a. Administration of protamine was associated with small and transient decreases in total white blood cells, granulocytes, and platelets, and with small and transient reductions in systemic and pulmonary arterial and left and right atrial pressures. Systemic vascular resistance fell (p = 0.07), and pulmonary vascular resistance rose but the change could be due to chance (p = 0.29). These data and those reported by others support the inference that complement activation occurs during CPB by the alternative pathway and again during protamine administration by the classic pathway; and that this accompanies a whole-body inflammatory reaction with blood cell and hemodynamic changes which, when extreme, could result in a severe hemodynamic derangement.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3947172     DOI: 10.1016/s0003-4975(10)62668-9

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  16 in total

1.  Clinical role of blood heparin level monitoring during open heart surgery.

Authors:  T Ohata; Y Sawa; S Ohtake; M Nishimura; C J Chan; K Suzuki; H Matsuda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-12

2.  Low molecular weight protamine (LMWP) as nontoxic heparin/low molecular weight heparin antidote (II): in vitro evaluation of efficacy and toxicity.

Authors:  L C Chang; J F Liang; H F Lee; L M Lee; V C Yang
Journal:  AAPS PharmSci       Date:  2001

3.  Complement activation during cardiac and thoracic vascular operations.

Authors:  P G Loubser
Journal:  Tex Heart Inst J       Date:  1987-12

Review 4.  The hemostatic defect of cardiopulmonary bypass.

Authors:  Matthew Dean Linden
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

5.  Methylene Blue to Treat Protamine-induced Anaphylaxis Reactions. An Experimental Study in Pigs.

Authors:  Agnes Afrodite S Albuquerque; Edson A Margarido; Antonio Carlos Menardi; Adilson Scorzoni; Andrea Carla Celotto; Alfredo J Rodrigues; Walter Vilella A Vicente; Paulo Roberto B Evora
Journal:  Braz J Cardiovasc Surg       Date:  2016 May-Jun

Review 6.  Lung inflammatory response syndrome after cardiac-operations and treatment of lornoxicam.

Authors:  Kosmas Tsakiridis; Andreas Mpakas; George Kesisis; Stamatis Arikas; Michael Argyriou; Stavros Siminelakis; Paul Zarogoulidis; Nikolaos Katsikogiannis; Ioanna Kougioumtzi; Theodora Tsiouda; Eirini Sarika; Ioanna Katamoutou; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

7.  The effects of complement activation during cardiopulmonary bypass. Attenuation by hypothermia, heparin, and hemodilution.

Authors:  F D Moore; K G Warner; S Assousa; C R Valeri; S F Khuri
Journal:  Ann Surg       Date:  1988-07       Impact factor: 12.969

8.  The beneficial effects of aminophylline administration on heparin reversal with protamine.

Authors:  S F Katircioglu; D S Küçükaksu; M Bozdayi; K Dalva; B Mavitaş; Y Zorlutuna; O Taşdemir; K Bayazit
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

9.  Effect of lornoxicam in lung inflammatory response syndrome after operations for cardiac surgery with cardiopulmonary bypass.

Authors:  Kosmas Tsakiridis; Paul Zarogoulidis; Giorgos Vretzkakis; Dimitris Mikroulis; Andreas Mpakas; Georgios Kesisis; Stamatis Arikas; Alexandros Kolettas; Giorgios Moschos; Nikolaos Katsikogiannis; Nikolaos Machairiotis; Theodora Tsiouda; Stavros Siminelakis; Thomas Beleveslis; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

Review 10.  Acute respiratory distress syndrome after cardiac surgery.

Authors:  Lisa Q Rong; Antonino Di Franco; Mario Gaudino
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.